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Background: Plasmodium knowlesi is one of five Plasmodium species known to cause malaria in humans and can
result in severe illness and death. While a zoonosis in humans, this simian malaria parasite species infects macaque
monkeys and serves as an experimental model for in vivo, ex vivo and in vitro studies. It has underpinned malaria
discoveries relating to host-pathogen interactions, the immune response and immune evasion strategies. This study
investigated differences in P. knowlesi gene expression in samples from ex vivo and in vitro cultures.
Methods: Gene expression profiles were generated using microarrays to compare the stage-specific transcripts
detected for a clone of P. knowlesi propagated in the blood of a rhesus macaque host and then grown in an ex-vivo
culture, and the same clone adapted to long-term in vitro culture. Parasite samples covering one blood-stage cycle
were analysed at four-hour intervals. cDNA was generated and hybridized to an oligoarray representing the P.
knowlesi genome. Two replicate experiments were developed from in vitro cultures. Expression values were filtered,
normalized, and analysed using R and Perl language and applied to a sine wave model to determine changes in
equilibrium and amplitude. Differentially expressed genes from ex vivo and in vitro time points were detected using
limma R/Bioconductor and gene set enrichment analysis (GSEA).
Results: Major differences were noted between the ex vivo and in vitro time courses in overall gene expression and
the length of the cycle (25.5 hours ex vivo; 33.5 hours in vitro). GSEA of genes up-regulated ex vivo showed an
enrichment of various genes including SICAvar, ribosomal- associated and histone acetylation pathway genes. In
contrast, certain genes involved in metabolism and cell growth, such as porphobilinogen deaminase and tyrosine
phosphatase, and one SICAvar gene, were significantly up-regulated in vitro.
Conclusions: This study demonstrates how gene expression in P. knowlesi blood-stage parasites can differ
dramatically depending on whether the parasites are grown in vivo, with only one cycle of development ex vivo,
or as an adapted isolate in long-term in vitro culture. These data bring emphasis to the importance of studying the
parasite, its biology and disease manifestations in the context of the host.
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Plasmodium invasion, growth and development in red
blood cells (RBCs) is a complex process entailing many
levels of controlled gene expression, receptor-ligand in-
teractions, host cell modifications, and communication
with the outside milieu. Each species of Plasmodium has* Correspondence: mary.galinski@emory.edu
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unless otherwise stated.between 5,100 and 7,700 or so genes [1], which as first
shown for Plasmodium falciparum, become differentially
expressed throughout the parasite’s intra-developmental
cycle (IDC) in the blood [2-4]. Understanding the multi-
tude of molecular and cell biological events required by
Plasmodium to successfully parasitize RBCs and evade
host defenses is paramount and increasingly within
reach with post-genomic approaches [5-7].
The development of a continuous in vitro blood-stage
culture system for P. falciparum was an essential step
towards significantly advancing research in many ofhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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development of malaria diagnostics, drug and vaccine
candidate interventions [8]. A comparably robust blood-
stage culture system is also available for the simian mal-
aria species Plasmodium knowlesi [9,10], but not other
primate malaria species. Attempts have been made to
develop continuous cultures of Plasmodium vivax [11]
and the very closely related simian malaria parasite
species Plasmodium cynomolgi [12], but the preference
for reticulocyte host cells along with other possible re-
quirements that have yet to be discovered have so far
prohibited the development of routine long-term culture
systems for these species [13-15].
While the utility of P. falciparum and P. knowlesi
in vitro blood-stage culture systems has been evident for
many avenues of research, including genetic manipula-
tion to study gene expression characteristics and deter-
mine functional traits, the biological states of parasites
in host organisms can differ substantially from that of
in vitro cultured parasites. For example, this became
evident for P. falciparum with recognition of the loss of
non-essential gene segments in culture [16] and reviewed
in [17]. Expression of the variant antigen var gene tran-
scripts from P. falciparum have also been shown to be-
come down-regulated when clinical isolates are adapted to
in vitro culture [18,19]. Numerous changing metabolic
and physical parameters in the parasite and host factors
are either different or lacking in vitro, which may affect
the parasite’s normal growth and biology. Investigations
have shown that even one altered parameter, such as glu-
cose level, can result in a marked change in gene expres-
sion profiles in cultured P. falciparum, with 560 genes
exhibiting a two-fold or greater change in the presence of
0.6 mM glucose compared to 11.1 mM glucose [20].
Notably, P. knowlesi can readily be studied in vivo,
ex vivo and in vitro, and it can potentially serve as a
model for P. falciparum or P. vivax; depending on the
scientific question. Plasmodium knowlesi is currently
also recognized as a species that can be transmitted to
and cause illness and death in humans [21-23]. Given its
broad utility, many critical basic malaria research discov-
eries have been made using P. knowlesi. These include
classic investigations of merozoite attachment to and in-
vasion of erythrocytes after the formation of a tight junc-
tion [24,25], the first report of the phenomenon of
antigenic variation (in rhesus monkeys) [26], and the
first identification of parasite-encoded variant antigens
expressed at the surface of infected RBCs; known as the
Schizont Infected Cell Agglutination (SICA) antigens
[27]. The SICA antigens are encoded by a large multi-
gene family known as SICAvar [28-30], which is func-
tionally analogous and evolutionarily related to the var
gene family in P. falciparum [31,32]; both gene families
are highly expressed in ring stages [28,30,33]. Expressionof the SICA proteins in vivo in rhesus monkeys is associ-
ated with the increased virulence of P. knowlesi, and
both the expression of these proteins and switching of
variant types at the surface of the infected host cells is
dependent on the presence of the spleen [34]. Recent
studies demonstrate for the first time that SICA[−] para-
sites lack full-length SICAvar transcripts and lack SICA
protein, consistent with apparent post-transcriptional
processing and translational repression [30].
Particularly now with the expanding potential for post-
genomic exploration of Plasmodium biology and patho-
genesis, and the use of comprehensive systems biology
approaches to understand host-pathogen interactions, it
is important to define and be cognizant of the similar-
ities and differences in gene expression that may occur
when Plasmodium is grown in a living host, compared
to in vitro. Here, these parameters are examined by
studying the stage-specific gene expression profiles of P.
knowlesi blood-stage parasites when grown in a rhesus
monkey followed by one cycle of ex vivo growth and de-
velopment compared to long-term in vitro culture. The
majority of the observed microarray signals correspond
to genes that are annotated in the current P. knowlesi
genome database as hypothetical. Of the various differ-
entially expressed (DE) known genes, it is striking that
signals representing a large number of SICAvar gene
transcripts were strongly up-regulated in the ex vivo
(ring-stage) samples, but not in the in vitro samples.
These observations in toto are germane for understand-
ing the biology of the P. knowlesi intraerythrocytic devel-
opment cycle (IDC) and the pathogenesis and virulence
of this species. The results are also highly pertinent as
indicators of what biological or biochemical networks
and pathways may likewise be affected when other spe-
cies including P. falciparum are grown and propagated
long-term under in vitro conditions.
Methods
Ethics statement
Animal experimentation reported here involved one ani-
mal (Macaca mulatta; rhesus macaque) and was con-
ducted in AAALAC-accredited facilities at the Yerkes
National Primate Research Center of Emory University
in accordance with the Animal Welfare Act and the
Guide for the Care and Use of Laboratory Animals.
Emory University’s Institutional Animal Care and Use
Committee (IACUC) approved this project’s experimen-
tal protocol. Temperatures in animal areas are con-
trolled and monitored by an automated on-line system.
The system has set parameters for high and low temper-
atures, maintained at 22°C ± 3°. The photoperiod is set
at a 12/12 cycle. Rhesus macaques are housed singly,
and provided with one of the following: forage board,
peanut feeder, challenger ball, or other similar device for
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tributed as prescribed to monkeys. Rhesus macaques re-
ceive jumbo biscuits (15% protein). Animals are fed
twice daily. The amount of food is adjusted depending
on species, sex, age, weight and specific number of ani-
mals living in a group. Consumption is monitored and
adjustments are made as necessary so that animals get
enough food with minimum waste. Enrichment produce
is fed twice weekly. All animals are monitored daily by
veterinary staff for potential health problems. Experi-
enced personnel trained all animals to voluntary present
at the front of the cage for skin prick using positive
reinforcement. For blood collection, as required by this
study, animals are sedated with Ketamine (10 mg/kg
IM), which is allowed no more than twice per 24 hours.
Per IACUC guidelines, maximum blood volume col-
lected cannot exceed 10 ml/kg/month. The one rhesus
macaque assigned to this study was treated and available
for other studies at the Yerkes National Primate Re-
search Center.
Parasite samples for microarray analysis
An ex vivo P. knowlesi blood-stage culture was initiated
using iRBCs from a rhesus macaque infected with the
Pk1(A+) clone of P. knowlesi [27]. The Pk1(A+) clone
was selected since the genomic DNA from this clone
was used to develop the first reported P. knowlesi gen-
ome sequence [35]. Briefly, a cryopreserved vial of ring-
stage parasites was thawed, processed and inoculated
into a rhesus monkey using standardized procedures.
Parasitaemia was monitored daily and whole blood was
collected into heparin-treated tubes when it reached 8%
ring-stage infected RBCs (iRBCs). The monkey was
treated with 15 mg/kg of chloroquine for 3 days to clear
the parasites. Collected whole blood was treated with a
final concentration of 2 mg/ml ADP (adenosine diphos-
phate bis salt) for 5 min before passage through a glass
bead column equilibrated with Hank’s balanced salt so-
lution to remove platelets, followed by passage through
a Plasmodipur filter. The filtered blood was centrifuged
for 5 min at 800 g and the pellet resuspended in RPMI
with L-glutamine, supplemented with 0.25% sodium bi-
carbonate, 50 ug/ml hypoxanthine, 7.2 mg/ml HEPES,
2 mg/ml glucose, 10% human AB+ serum. The iRBCs
were cultured at 1 × 107 iRBCs/ml in multiple 175 cm2
flasks (one per time point, TP) and gassed with 5%: 5%:
90%, O2:CO2:N2. One culture flask was processed every
four hours over a 24-hour period for extraction of para-
site RNA, and these samples were designated as ex vivo
TP #s 1–6.
For the in vitro time course samples, a cryopreserved
vial of culture-adapted Pk1(A+) parasites was thawed
using standardized procedures, and expanded in RPMI
with L-glutamine, supplemented with 0.25% sodiumbicarbonate, 50 ug/ml hypoxanthine, 7.2 mg/ml HEPES,
2 mg/ml glucose, 10% human AB+ serum. Fresh rhesus
RBCs were added as necessary, and the parasitaemia was
maintained at less than 10%. The culture was synchro-
nized by consecutive Percoll (52%) and sorbitol treat-
ment in which RBCs were suspended in 5X volume of
pre-warmed 5% sorbitol, incubated for five minutes and
washed three times in RPMI [36]. Since the in vitro cul-
tured parasites develop at a slightly slower rate than
in vivo, a 28- or 32-hour time course plan was designed
for RNA extraction, with iRBC collection every four
hours. Samples were generated representing two bio-
logical replicates (I and II), with samples for seven TPs
collected for the first replicate and eight for the second;
the eighth TP was particularly aimed at collecting very
mature segmenting schizonts.
RNA extraction
For the first two time points from the ex vivo culture,
1 × 1010 iRBCs were collected and put into Trizol LS
(Invitrogen) at a 1:10 pellet to reagent ratio, vigorously
shaken for 1 min, incubated at 37°C for 5 min, and
stored at −80°C. For all other time points from the
ex vivo culture, 5 × 109 iRBCs were collected. At the
last time point, a 1:20 pellet to Trizol LS ratio was
used to extract RNA. All samples were immediately
stored at −80°C. For the in vitro cultures, approxi-
mately 5 × 109 parasites were collected for the first
two time points, and 1 × 109 parasites were collected
for the remaining time points. To purify the total
RNA, the parasite/Trizol samples were thawed at room
temperature and transferred to 30 ml Teflon tubes.
One ml chloroform per 5 ml sample volume was
added and vigorously shaken for 1 min before centri-
fuging at 12,000 g for 30 min at 4°C. The aqueous
layers were removed to a 30 ml polypropylene tube,
0.8 volume of isopropanol added, and incubated over-
night or for at least 2 hours at −20°C before centrifu-
ging at 12,000 g for 30 min at 4°C. The supernatant
was carefully removed and the pellet was allowed to
dry for 5–10 min at room temperature and then resus-
pended in 1 ml of RNase-free water. The sample was
purified using the RNeasy midi kit (Qiagen) following
the manufacturer’s instructions.
Proteomic analysis
Briefly, late stage trophozoites from synchronized cul-
tures were purified with 52% percoll, washed 3 times
with incomplete RPMI 1640, resuspended in SDS sample
buffer and stored at −80°C. Immunoprecipitation with a
pan-SICA antibody was performed as in [30]. Peptides
were generated as previously described [31]. Protein
bands were excised from SDS-PAGE gels and gel pieces
destained and dried. Dried gel bands were digested at
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(Sigma, St. Louis, MO, USA). The resulting peptides
were then extracted with 0.1% trifluoroacetic acid in
50% acetonitrile (Sigma), desalted and concentrated
using ZipTip pipette tips containing C18 reversed-phase
media (Millipore, Billerica, MA), and then washed in
0.1% trifluoroacetic acid and eluted in 0.1% trifluoroace-
tic acid/50% acetonitrile (Sigma). Cleaned peptides were
analysed by reverse-phase LC-MS/MS using an LTQ-
Orbitrap mass spectrometer (Thermo Finnigan). A reverse
database strategy using the SEQUEST algorithm was im-
plemented to evaluate false discovery rate; the matched
peptides were filtered according to matching scores to re-
move all false matches from the reverse database [37].
Only proteins that were matched by at least two peptides
were accepted to further improve the confidence of identi-
fication. The peptides were then searched against the
NCBI database, with searches being limited to Plasmo-
dium results. The P. knowlesi identified protein
sequences were then used to BLAST (Basic Local
Alignment Search Tool) against the NCBI database for
sequence homologies.
Data analysis
Reannotation of oligonucleotide probes
A set of 60-mer oligonucleotide probes (Additional file 1)
developed prior to the publication of the P. knowlesi
genome was reannotated based on the genome sequence
reported in PlasmoDB V8.2. All the oligonucleotides in
the array were BLASTed against the PlasmoDB V8.2
sequences using NCBI BLAST 2.2 with the parameter of
E-value cutoff at 0.1. Only oligonucleotides with unique
hits to protein-coding regions were kept for further ana-
lysis. The unique hit oligonucleotides were defined as
probes having high first-hit bit scores (>85) and low
second-hit bit scores (<60) or probes having second-hit
bit scores equal to 0. Of the 4,799 P. knowlesi probes
found to have unique hits, 4,755 representing 4,700
protein-coding genes were used in the analysis.
Determining the periodicity of gene expression
Microarray hybridization, data filtering and normalization
All data were processed using R and Perl language. The
workflow is shown in Additional file 2. cDNA synthesis,
Cy dye labelling, as well as microarray hybridizations of
the time course samples were carried out as described
previously [38]. For each P. knowlesi time course, sam-
pling time point RNAs labelled with Cy5 were hybrid-
ized against a reference RNA pool labelled with Cy3
(consisting of equal amounts of P. knowlesi RNA from
each time point). Microarray hybridizations were carried
out on a chip with 4,992 60-mer oligonucleotides repre-
senting 4,700 coding genes designed for P. knowlesi, with
the remainder representing P. vivax genes. Microarraydata acquired with GenePix Pro 6.0 software (Axon
Instruments, USA) were filtered for quality control by
accepting only features with Cy3 and Cy5 signal inten-
sities higher than two-fold of the microarray background
intensities. The log2 ratio of Cy5/Cy3 intensity was
calculated after background subtraction and was nor-
malized using locally estimated scatterplot smoothing
(LOESS) in marray package of R. To reduce technical
noise between experiments, robust quantile normalization
was applied to the data across all time points to achieve
the same distribution of log2 ratios (Affy package of R).
After normalization, probes were filtered out that had
more than two missing values across all time points for
any one of the three time courses, resulting in 4,198
probes, representing 4,165 protein-coding genes that were
used for further analysis (Additional file 3). The micro-
array probe ratios were averaged for multiple probes of a
particular gene. Data for the microarrays and probe infor-
mation are available at the Gene Expression Omnibus
database at the National Center for Biotechnology Infor-
mation [GEO: GSE62886, GPL19374].
Sine wave modelling
To compare gene transcription between the iRBC sam-
ples without knowing the exact time post-invasion, a
sine wave model was applied. The function is described
in Figure 1d. t is the time (hours) at each time point,
and y(t) is the corresponding transcription levels at each
time point. Equilibrium is the average level of one
complete sine curve. It was assumed to be the balanced
transcription level of a gene across the life cycle, an ori-
ginal state that a gene would return after expression
peak, valley and any expression changes. Amplitude is
the transcription level change according to equilibrium,
visually represented as the vertical distance between the
extrema of the sine curve and the equilibrium value. h is
the period of one complete life cycle expressed in hours
and phase is the fraction of one life cycle indicating the
time offset of an expression peak to the time point at
one quarter of the life cycle. For each gene, the parame-
ters equilibrium, amplitude, and phase were determined
and h optimized within 12 to 48 by the sine wave model
to find a sine function that best fits the periodical pat-
tern of gene transcription levels across the life cycle.
Phase adjustment
Phase is the initial angle of a sinusoidal function at its
origin. It indicates the time offset of an expression peak
to time zero. The magnitude of the phase correlates to
the timing of the peak expression of a gene. Since it is
difficult to synchronize cells at the exact same starting
time, the calculated phase for the same gene from time
course to time course would differ. Therefore, phase ad-
justment is required to adjust for these differences.
Figure 1 (See legend on next page.)
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Figure 1 Periodical transcription of P. knowlesi genes during the IDC. Transcriptomes showing 4,165 PK genes of the ex-vivo (a) and two
in-vitro samples (b,c) of the time course sampled at 4 hour intervals over 24–32 hours in culture. First column represents raw data during time
courses; second column represents raw data after median centered normalization and third column represents equilibrium value centered data
after smoothing by sine functions with H = 27 for ex vivo and H = 33 for in vitro. (d) Sine wave model and its equation. t is the time (hours) at
each time points, and y(t) is the corresponding transcription levels at each time point. Equilibrium is the average level of one complete sine
curve. Amplitude is visually represented as the vertical distance between the extrema of the sine curve and the equilibrium value. h is the period
of one complete life cycle expressed in hours and phase is the fraction of one life cycle indicating time offset of an expression peak to the time
point at one quarter of life cycle. (e) Prediction of duration for a complete cycle of ex vivo and in vivo samples (period time). 873 genes from
ex vivo sample, 879 and 1117 genes from in vivo samples I and II significantly fit a sine curve (p value < 0.05 and amplitude above median) and
were used to predict the period. The median period is 25.5 hours for ex vivo sample, and 33.5 hours for in vitro samples.
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were estimated for each gene at each hour during its life
cycle to give rise to 25 time points (ex vivo) and 33 time
points (in vitro). The in vitro time points were mapped
to ex vivo time points by determining the highest corre-
lated time point between ex vivo and in vitro expression
profiles (Additional file 4). To make the result more reli-
able, only 219 genes having significant periodical expres-
sion patterns were used (p value < 0.05 and amplitude
>0.3 of their sine curve) in all three samples. Phase shift
was estimated for each in vitro time point based on the
corresponding ex vivo sample. The average of phase shift
then was used as the delta phase, 0.85 between in vitro I
and ex vivo, 1.4 between the biological replicate in vitro
II and ex vivo.
Functional enrichment analysis
Gene set enrichment analysis (GSEA) was carried out
based on GO terms, KEGG pathway and MPM pathway
annotated for each P. knowlesi gene according to their P.
falciparum orthologs (PlasmoDB v8.2) [39]. 4,570 of
5,197 protein-coding genes in P. knowlesi have orthologs
in P. falciparum (3,838 P. knowlesi genes with at least
one GO term, 761 genes with at least one KEGG identi-
fication, and 2,346 genes with at least one MPM identifi-
cation). In the gene enrichment analysis, only functional
groups with more than 10 genes were considered. In
addition, another eight functional groups were added in-
cluding SICAvar, kir and others derived from recent
work [40].
Differential expression analysis by time point
For each microarray, logarithms of fold changes between
the various experimental time point sample RNAs and
reference RNAs were first computed for all genes. Then
cross-array normalization was applied to remove global
technical biases brought by different arrays. For each
array the log-fold changes were shifted and rescaled so
that they have the same means and variances. There are
expression values for each gene at six time points for the
ex vivo time course and seven time points for the two
in vitro time courses. To make the data comparable for
different samples, the seven expression values for thein vitro samples were mapped into six time points by
interpolation (Additional file 5).
Assessing global differences in gene expression among
the three time courses
To assess the global differences in gene expression
among the ex vivo and in vitro samples, the pair-wise
differences of expression were computed among the
three samples for all genes. For a gene, the difference
score between two samples is defined as the Euclidean
distances for its expression at all time points. Smaller
distance means greater similarity. By doing so three dif-
ference scores were obtained for each gene, whereby
each represents the difference between a pair of samples.
For a gene, if the difference score between the two
in vitro samples is the smallest among the three, it indi-
cates that the expression of that gene is more similar be-
tween the in vitro samples.
To rigorously assess the significance of this propor-
tion, a randomization test was performed. In each per-
mutation, gene labels were randomly shuffled for all
samples but the time points were kept unchanged. Then
the pairwise difference scores were recomputed for all
genes, and the number of genes with difference scores
between the in vitro samples being the smallest was
computed.
Detecting individual differentially expressed (DE) genes
To detect individually DE genes from ex vivo and
in vitro samples, the two sets of in vitro samples were
treated as biological replicates. DE genes at each time
point were detected using limma R/Bioconductor soft-
ware package [41]. To detect DE genes considering data
from all time points, a functional t-test procedure was
adopted [42]. Specifically, for each gene a modified t-
statistic was computed at each time point, and then the
maximum of the t-statistics from all time points was ob-
tained as the test statistics for the gene. The critical value
for differential expression can be obtained through a per-
mutation test. Because of the small sample size, stringent
criteria were used and the maximum of all t-values from
all permutations were used as the threshold for defining
DE genes.
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Microarray experiments were performed to evaluate the
global gene expression profiles of P. knowlesi blood-
stage parasites as they mature in host red blood cells,
from ring to trophozoite and schizont stages of develop-
ment, and compare the profiles between ex vivo cultures
and in vitro adapted cultures. An overarching purpose of
this research was to determine which gene expression
patterns if any may be dependent on the presence of
host factors.
A P. knowlesi infection was established in a naïve rhe-
sus monkey and the maximum blood volume allowed by
IACUC guidelines and approved protocols (10 ml/kg/
month) was drawn to obtain ring-stage iRBCs for ex vivo
culture and the collection of stage-specific samples every
4 hours over the parasite’s 24-hour IDC. Plasmodium
knowlesi asexual stage development is synchronous
in vivo, making this readily feasible, beginning with ring-
stage iRBCs collected from a blood draw. It would have
been ideal from a scientific standpoint to obtain blood col-
lections throughout the IDC, but, per IACUC guidelines,
animals may only be sedated twice/day, and in addition to
logistical limitations of the availability of animal resource
staff over a 24-hr period, ex vivo cultures were by neces-
sity initiated when the iRBCs were at the ring stage of
development.
For comparison, two biological replicates were gener-
ated from in vitro adapted cultures, which do not main-
tain synchronous growth [9]. Acquiring these samples
for comparison with the ex vivo cultures, therefore, re-
quired synchronization steps (see Methods). The first
in vitro time course was collected over 28 hours. For the
second in vitro time course an additional sample TP was
collected at 32 hours to obtain segmented schizonts, the
final stage of the parasite’s growth before the release of
merozoites. These cultures were maintained by the
addition of freshly acquired RBCs from a different rhe-
sus macaque than the one used for the ex vivo time
course; in our view the specific host RBCs themselves
would have negligible impact on the transcription pro-
files over one cycle compared to the culture environ-
ment (ex vivo versus long term in vitro). Notably, the
Pk1(A+) line is routinely grown in culture medium sup-
plemented with human AB+ serum. An overarching goal
of this work is to compare parasite biology when
adapted to widely available long-term culture conditions
versus ex vivo. For this reason and consistency through
multiple experiments, human AB+ serum pooled from
10 different donors was used in lieu of rhesus macaque
serum.
Periodicity of gene expression in the P. knowlesi IDCs
To test for periodicity of gene expression in the P. know-
lesi IDCs, sine wave regression was carried out for eachexpressed gene during the established time courses.
3,684 (~88.5%) out of the 4,165 genes examined on the
array significantly fit to a sine curve with a p value <0.05
(F test) for at least one of the time courses. These ana-
lyses confirm that a majority of the parasite’s genes are
transcribed periodically during the blood-stage cycle
(Figure 1a, b and c), and each gene’s transcriptional pro-
file can be fit to a sine wave with a determined equilib-
rium, amplitude and frequency (Figure 1d). For each
time-course experiment, the time required for the para-
site to complete the blood-stage cycle of growth and de-
velopment was estimated. For each gene, varying the
cycle length from 12 hours to 48 hours identified the
best-fit sine curve, and the optimized sine function with
the minimum F test p-value was gained. Based on this
assumption, the length of each blood-stage cycle was es-
timated from genes that were significantly fitted by a
sine curve (p value < 0.05) and amplitude above the me-
dian (based on 873 genes for the ex vivo time course,
and 879 and 1,117 genes for the in vitro I and II time
courses, respectively).
Parasites grown under in vitro conditions developed at
a significantly slower rate (25 hours ex vivo versus
33 hours in vitro) (p value < 2.2e-16) (Figure 1e). Sine
wave models were therefore established separately with
the periodic time as 25 hours and 33 hours for the
ex vivo and in vitro samples, respectively. Smoothed
transcription profiles are shown in the second columns
of the heat maps in Figure 1a, b and c. In addition, the
age of the parasite at the start of the TP collections
(TP1) was markedly different for each time course when
the pair-wise correlation of TP1 was calculated between
the time courses. This is a reflection of the inherent
difficulty in precisely matching the ages of ring-iRBCs
acquired directly from a rhesus macaque infection with
those from synchronized in vitro cultures. Hence, data
processing and adjustments were necessary to compare
the ex vivo and in vitro transcriptomes.
Comparative overview of the transcriptomes
Using the sine wave model, DE genes between the
transcriptomes were defined based on equilibrium, amp-
litude and phase parameters as calculated for each gene.
Distinctive gene expression differences were not noted
between the two in vitro transcriptomes by these methods,
or others, and pair-wise differences of gene expression
among the three time courses (ex vivo, and the two
in vitro biological replicates) indicate that 77% of the
expressed genes are in fact more similar between the
in vitro time courses (Figure 2a). In a randomization test
based on 1,000 permutations, the permutation p-value
was determined to be less than 0.001. These results
strongly indicate that the gene expression profiles derived
from the two in vitro time courses are much more similar
Figure 2 Overall differences between in vitro and ex vivo time courses. (a) The distributions of pair-wise difference scores for all genes
showing the similarity of the two in vitro experiments and how they differ from the ex vivo experiment (b) the distributions of pair-wise difference
scores from a permutation showing that the difference scores do not occur by chance. (c) Comparison of amplitude, equilibrium and phase
between ex vivo and in vitro samples. These plots show the distribution of pair-wise difference of amplitude, equilibrium and phase values of
ex vivo and in vitro I (red), ex vivo and in vitro II (pink), and in vitro I and in vitro II (blue). The amplitude difference was defined between ex vivo
and in vitro as the minimum difference between ex vivo and the two in vitro named as D-EVamp and the amplitude difference between the two
in vitro samples as D-VVamp. The equilibrium difference (D-EVeqm and D-VVeqm,) and phase difference (D-EVph and D-VVph) were similarly defined.
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the ex vivo samples (Figure 2b). The pairwise differences
in amplitude (p value < 2.2e-16) and equilibrium (p value
< 2.2e-16) are significantly smaller between in vitro sam-
ples than between in vitro and ex vivo samples. In
addition, the amplitudes of gene expression were found to
be significantly higher for the ex vivo TPs than the in vitro
TPs (p value < 2.2e-16), which is likely a result of the
greater degree of synchronicity of the ex vivo culture. In
the phase analyses, as expected, no significant changes
were observed among the ex vivo and in vitro samples
(Figure 2c).
Differentially expressed genes in equilibrium and
amplitude
Differentially expressed genes were defined in equilib-
rium and amplitude based on the criterion that the
minimum differences among the ex vivo and each of the
two in vitro cycles were greater than the differences
noted from the in vitro replicates. Taking all 4,165considered genes into account, 2,009 transcripts were
identified with changes in equilibrium and 2,355 tran-
scripts with changes in amplitude. The distributions of
gene numbers at each fold change are shown in Figure 3.
GSEA was performed as described using P. knowlesi
orthologs of P. falciparum genes belonging to annotated
functional gene sets/pathways from KEGG, GO and
MPM databases [43-45], in addition to several P. know-
lesi specific gene sets including the predominant large
SICAvar and kir multigene families.
Importantly, among the 1,029 (~51%) genes that were
up-regulated in equilibrium in the ex vivo samples, there
was significant enrichment in genes coding for SICA
proteins (FDR = 0). Other genes noted in this category
are associated with biological processes relating to RNA
transport, translation initiation, and phagosomes. Con-
versely, 980 (~49%) of the genes that were down-regulated
in equilibrium showed enrichment in transcripts involved
in multiple biochemical pathways associated with nucleo-
some and chromatin assembly and organization, as well as
Figure 3 Histogram showing the frequency of DE genes in terms of fold change between ex vivo and in vitro samples with respect to
amplitude and equilibrium (log2 scale). (a) Number of genes differentially expressed in equilibrium at each fold change cutoff (b) Number of
genes differentially expressed in amplitude at each fold change cutoff. The majority (~89%) of genes were up regulated.
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proteins, and Maurer’s cleft related proteins (FDR < 25%,
Figure 4a). Genes associated with ribosomal structure and
fatty acid synthesis and certain organellar specific proteins
(plastid, mitochondrion and ER) are among those that
were less so, but also noticeably down-regulated in the
ex vivo culture.
A majority (2,108 or ~89%) of genes with changes in
amplitude were up-regulated in the ex vivo cultured par-
asites. These genes mainly include ribosomal associated
genes, SICAvar genes, Maurer’s Cleft related protein
genes and histone acetylation pathway genes, while the
down-regulated genes (247, ~11%) showed an enrich-
ment to just a few invasion-related genes (FDR < 25%,
Figure 4b). As a whole, the results reveal that the ex vivo
parasite has an overall higher capacity for transcribing
certain genes involved in the interaction of host-
parasites with larger stage-specific amplitudes, an effect
apparently resulting directly from the in vivo growth of
the parasite in rhesus monkeys, and in support of predic-
tions to this effect. The up-regulated genes are accompan-
ied by lowered transcription of various metabolic pathway
genes such as for DNA replication, protein degradation
and chromatin organization.
Significant DE genes were defined by applying the cri-
terion that the minimum difference between the ex vivo
and each of the in vitro cycles was greater than 1.5-fold
(equal to Mean ± ~1.5 SD) of the difference between the
in vitro replicates. 95 and 130 genes were up-regulated,
and 162 and two genes were down-regulated, in equilib-
rium and amplitude, respectively.
Differentially expressed genes by stage specificity
To determine if the DE genes were biased towards any
particular stage in the IDC, the transcription profiles ofall DE genes were averaged, as shown in Figure 5a, b
and c. Genes that were up-regulated in equilibrium in
the ex vivo culture were most highly expressed in the
early ring stage and late stage schizonts (Figure 5a),
while genes that were down-regulated in the ex vivo
culture had peak expression in the trophozoite and
early (2–4 nuclei) schizont stages (Figure 5b). Simi-
larly, genes that were up-regulated in amplitude in the
ex vivo culture were also highly expressed in the
trophozoite stage (Figure 5c). The major significantly
enriched functional pathways for the DE genes had
peak expression that coincided with the stage of peak
expression observed here.
Taking all TPs into consideration using an alternative
method that assesses calculated pairwise differences, 650
genes were found to be DE (FDR adjusted p-value < 0.01)
between the ex vivo and in vitro samples. The majority of
these genes (403; 62%) were annotated in the P. knowlesi
genome database (Pk4 assembly) as hypothetical genes
[1,35]. Of note, sequences representing 32 SICAvar gene
IDs were shown to be differentially up-regulated at the
ring stage, which corresponds to 38% of the 101 SICAvar
gene oligonucleotides present on the array (Figure 6).
These 101 oligonucleotides represent 99 unique SICA-
var gene IDs plus two contigs with SICAvar gene se-
quences with most annotated at the time of this study
as gene fragments [35]. Some have since been con-
firmed as contiguous sequences that are part of the
same gene [30]; others occur next to gaps in the assem-
bly [35]. Thus, the SICAvar oligonucleotides on the
microarray do not represent the entire reported SICA-
var gene family, which had been estimated at 107 or
108 members [29,35]. An updated P. knowlesi genome
is forthcoming, which resolves many of these gaps
(Chappell et al., personal communication).
Figure 4 (See legend on next page.)
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(See figure on previous page.)
Figure 4 Functional enrichment analysis of DE genes using GSEA software. (a) Significantly enriched functional groups for genes differentially
expressed at equilibrium levels (FDR < 25%, p value <0.05) (b) Enriched functional group of DE genes in amplitude (FDR < 25%). Red color represents
up regulated genes. Green color represents down regulated genes. The short lines indicate genes from the corresponding functional pathway that is
shown in the header.
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family members represented on the array were identified
as DE over all TPs. Unlike the SICAvar genes, the kir
genes were not up-regulated preferentially in the ring
stages. Two kir genes were identified as being DE at TP1
(rings), four at TP2 (early trophozoites), and two at TP6
(schizonts). The remaining DE genes include 31 riboso-
mal genes (4.5%) and various genes involved in either
protein synthesis or processing.
Genes differentially up-regulated ex vivo
A number of other genes were found to be specifically
up-regulated in the ex vivo cultured parasites (Additional
file 6, Panels 1–6). The majority of these were more
highly expressed in the earliest and latest stages ofFigure 5 Average transcription profile and heatmap of DE genes duri
equilibrium (b) 162 down regulated in equilibrium (c) 130 up-regulated indevelopment (Figure 6). This subset includes genes in-
volved in proteolysis (PKH_011450, proteasome subunit
beta type gene) and radical-based catalysis (PKH_144460,
radical S-adenosyl methyltransferase protein gene), rele-
vant for diverse metabolic reactions including biodegrad-
ation pathways. Interestingly, PKH_143910, the putative
ApiAP2 transcription factor exhibited similar dynamics
ex vivo and in vitro, but at a much higher level ex vivo, es-
pecially at earlier stages. Differential expression of genes
involved in transcription in early stages has been docu-
mented before in P. falciparum [2,4]. Some unexpected
transcripts were also detected such as the P. knowlesi
homolog of pfg377 (PKH_146780), which encodes a pro-
tein that is specifically found on female gametocytes, and
the PSOP12 homolog (PKH_101880) that encodes ang time courses (fold change > 1.5). (a) 95 genes up-regulated in
amplitude.
Figure 6 Box plot showing p-values at the six different time points
comparing the ex vivo and in vitro experiments. The boxes are
higher in the middle, reflecting the larger p-values and the fact that the
gene expression patterns are more similar for time points three and four.
Lapp et al. Malaria Journal  (2015) 14:110 Page 12 of 16secreted protein at the ookinete stage. Gametocytes are
often produced when the parasitaemia reaches high levels
in rhesus macaques, and this could explain the detection
of the pfg377 homolog transcript. The ookinete protein
could either have a separate function in the blood-stage
parasites, or it is possible that the transcript is produced
and maintained early, prior to its ultimate translation in
the insect stage.
Genes differentially up-regulated in vitro
Only a few genes were found to be up-regulated in the
in vitro compared to ex vivo-cultured parasites (Additional
file 6, Panels 6–8). Most of these genes were expressed at
higher levels in the later stages of the IDC. Several genes
involved in metabolism and cell growth were significantly
up-regulated in the in vitro cultures: e.g., porphobilinogen
deaminase (PBGD) (PKH_130850) and protein tyrosine
phosphatase (PKH_122120). The former is involved in the
haem biosynthesis pathway, catalyzing porphobilinogen to
uroporphyrinogen III (UROGEN III) (EC 2.5.1.61) [1,46].
The host PBGD, also called hydroxymethylbilane synthase,
is most highly expressed in the spleen and bone marrow
in humans based on tissue-specific ESTs (Additional file
7) [47]. Plasmodium parasites utilize host haem synthesis
proteins in their erythrocytic life cycle in addition to their
own de novo pathway [48], however the host PBGD is
much more efficient [46]. It could be expected, then, to
see parasite PBGD up-regulated when the host enzyme is
dysregulated, as in a splenectomized host, or in in vitro
culture. Conversely, if erythropoiesis is stimulated in the
bone marrow during malaria infection, host PBGDmay become up-regulated, decreasing the requirement
of parasite de novo synthesis. Finally, one SICAvar gene
(PKH_020570) was highly up-regulated in vitro in the
schizonts (TP6), and less so in the ring-stage (TP1 and
TP2) samples. While this could mean that this SICAvar
gene or encoded protein has a unique role for the para-
site’s biology, the protein encoded by PKH_020570 was
not identified in any blood-stage samples so far ana-
lysed by LC-MS/MS. It is also intriguing that this gene
was also found to be up-regulated in P. knowlesi in-
fected RBCs from a splenectomized animal (manu-
script in preparation).
Invasion and basic metabolic functions
The basic invasion, growth and multiplication mecha-
nisms of P. knowlesi parasites in vivo, ex-vivo and in vitro
are similarly efficient. In each case, within a similar time
frame (25 to 33 hours), the merozoites effectively enter
RBCs and transform through the trophozoite and schizont
stages of development to produce progeny merozoites. As
anticipated, transcripts representing genes encoding pro-
teins known to be involved in the invasion of RBCs were
similarly detected, reflecting common IDCs for both the
ex vivo and in vitro parasite samples; e.g. apical membrane
antigen 1 [49], merozoite surface protein 3 [50,51], rhoptry
associated proteins [52], and reticulocyte binding protein
homologs [53,54] (see Additional file 6 Panels 14–22).
Merozoite surface protein 1 (PKH_072850) did exhibit an
oscillating pattern over time in one of the in vitro replicate
experiments. All in all, while similarities were noted in
many such comparisons, it remains possible that subtle
differences and unnoticed temporal factors may make a
big difference in the expression of various genes and the
timely function of the encoded proteins. Small or subtle
differences in transcript patterns detected may have an
impact on protein expression and function, but overall the
data are consistent with the fact that the ex vivo and
in vitro-derived parasites efficiently invade and grow in
rhesus RBCs. The differences in the timing of the blood-
stage cycles, likely simply reflect the adjustment of the
parasites from the synchronization procedures. It is also
worth noting that similar transcript levels were found for
genes with various basic metabolic functions. For example,
14-3-3 and actin transcripts were detected at similar levels
(Additional file 6, Panels 25–26). Genes annotated as
encoding blood-stage membrane proteins and integral
membrane proteins were also examined, and with the ex-
ception of the SICAvar gene family (discussed below),
found no significant differences (Additional file 6, Panels
23–24).
Epigenetic regulation
It is important to know whether Plasmodium genes that
encode proteins involved in epigenetic regulation are
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culture, especially given increasing knowledge of the
importance of epigenetic regulation in Plasmodium
[55-59], including the specific role of epigenetic regu-
lation originally attributed to var gene expression in P.
falciparum [60,61]. Overall, genes encoding histone
and histone-modifying proteins exhibited similar levels
of expression throughout the IDCs in the parasites
grown ex vivo and in vitro. Interestingly, however, sir2
transcripts (PKH_122390) were more abundant in the
late stages of ex vivo parasites compared to in vitro
(Additional file 6, Panel 13). Further analysis is re-
quired to determine if this difference in expression is
critical for the in vivo expression of SIR2 in relation to
the specific regulation of the SICAvar gene family and
the up-regulated expression of many SICAvar tran-
scripts in the ring-stage parasites ex vivo.
SICAvar gene expression is dramatically down-regulated
in vitro
The normalized intensity values of SICAvar genes were
inputted into the Cluster program and visualized with
TreeView (Figure 7). These data clearly show that the
SICAvar gene family as a whole is down-regulated
when the iRBCs are grown in vitro. In the ex vivo cul-
ture, the SICAvar gene IDs with the highest level of
transcript expression demonstrated by the microarrays
are PKH_050020 and PKH_072700/PKH_072710 (the
latter two gene IDs represent a single SICAvar gene).
These gene IDs were identified by LC-MS/MS for the
P. knowlesi clone known as Pk1(A+), from which the P.
knowlesi microarray oligonucleotides were based, but
not for the Pk1(B+)1+ clone [30]. Also detected at a
high level was PKH_113950, which is highly expressed
in the Pk1(B+)1+ clone [30]. However, a recent BLAST
search revealed that the PKH_113950 oligonucleotide
probe hits another SICAvar gene, PKH_020270, with
100% identity.
It was also determined if SICA proteins could be de-
tected in the in vitro cultured parasites using LC-MS/
MS and found only one unique peptide corresponding
to one SICA protein (PKH_030540); this contrasts to a
high level of expression of multiple SICA proteins in
established clones from rhesus macaque infections [30].
These findings are comparable to what is observed when
P. knowlesi SICA[−] blood-stage parasites are grown in a
splenectomized rhesus monkey, in which case neither
functional full-length SICAvar transcripts nor SICA pro-
teins are observed [30]. It has been known that the pres-
ence of the spleen is necessary for the expression and
switching of SICA phenotypes in vivo [34], and that the
spleen also has an apparent role in the expression of
PfEMP1 encoded by the var genes and cytoadherence
[62-64]. Whether only host splenic factors are criticalfor the expression of the SICAvar gene family or also
other host influences is unknown. Similar questions re-
main valid with regards to the expression of the P. fal-
ciparum var genes in vivo. The stage-specific ex vivo
microarray data are consistent with published expression
library screening and standard RT-PCR experiments
showing that many SICAvar genes are expressed as tran-
scripts in the ring stage of development, without any evi-
dence for the predominant transcription of any particular
SICAvar transcript(s) [28-30,65].
One possible interpretation of these microarray data
with regard to antigenic variation is that the default state
for SICAvar genes in P. knowlesi is ‘off ’, and that there
are host cues that turn them ‘on’. The spleen is one pre-
dicted source of these cues, since it has been shown that
SICA protein expression at the surface of iRBCs is lost
after passage in splenectomized hosts [34], and it has
been shown quantitatively that the level of SICAvar tran-
scripts detectable in splenectomized hosts is minimal in
comparison with intact hosts. Moreover, full-length
SICAvar transcripts are not detected in RNA extracted
from SICA[−] parasites [30].
Conclusions
This stage-specific microarray analysis shows a marked
difference in gene expression between P. knowlesi blood-
stage parasites derived from a rhesus monkey infection
and P. knowlesi parasites adapted for in vitro culture. Most
strikingly, expression of the SICAvar variant antigen
genes, which are related to the P. falciparum var genes
and associated with increased virulence in vivo [28,31,34]
is up-regulated in the ex vivo cultures. Thus, in vitro cul-
tures can provide a negative phenotype (in the “off state”)
for SICAvar gene expression in comparison with ex vivo
samples (in the “on state”), similar to what has been dem-
onstrated in splenectomized hosts [30,34,63,66]. Ex vivo
cultures would therefore be important for unraveling the
molecular mechanisms that control SICAvar gene expres-
sion and switching. Further investigations are required to
evaluate what other genes may be implicated in the regu-
lation of the SICAvar and potentially var gene family in
the context of the in vivo host environment. Subsequent
studies (Lapp, Chappel et al., personal communication)
using RNA-Seq technologies will provide useful compari-
sons to expand upon the findings reported here.
Other clear examples of up-regulated and down-
regulated genes were also detected between the ex vivo
and in vitro P. knowlesi samples, which should be taken
into consideration when aiming to understand the para-
site’s natural programmed growth and development with
the inherent influence of host factors in vivo. Critically,
the data reported here bring emphasis to the fact that
host-derived biological cues are important for Plasmo-
dium gene expression.
Figure 7 Heat map of all SICAvar genes in the ex vivo and two in vitro experiments, based on normalized intensity values.
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